Bliss Kelly 4/A

4/A · Teladoc Health, Inc. · Filed Mar 12, 2026

AI-generated summary of this filing

Updated Mar 12, 2026

Teladoc (TDOC) Bliss Kelly Receives Performance Stock Units

What Happened

Bliss Kelly, President, U.S. Group Health at Teladoc Health (TDOC), was granted 15,596 performance stock units (PSUs) and reported an exercise/conversion of 5,198 derivative units on Feb 27, 2026. Both transactions are reported with a $0 per-share price (award/derivative conversion, not an open‑market cash sale or purchase).

Key Details

Transaction dates: reported as Feb 27, 2026 (Form 4 filed as an amendment on Mar 12, 2026; original Form 4 filed Mar 3, 2026 contained an incorrect award amount).
Grants: 15,596 PSUs @ $0.00 (award/derivative acquisition).
Exercise/conversion: 5,198 derivative shares @ $0.00 (reported as disposed; no cash proceeds reported).
Vesting/conditions: PSUs are performance-based (measured against 2025 financial results) and convert one-for-one to common shares. One‑third vests on March 1, 2026, with the remainder vesting in eight substantially equal quarterly installments thereafter.
Shares owned after transaction: not specified in the amended filing.
Filing status: This is an AMENDED Form 4 correcting the number of PSUs reported in the March 3, 2026 filing.

Context

These entries are compensation-related derivative transactions (performance stock units) rather than open‑market buys or sales; PSUs reflect contingent rights to receive shares if performance/vesting conditions are met. The exercise/conversion reported at $0 typically reflects conversion/settlement mechanics rather than a paid purchase or an immediate cash sale.

Form 4/AAmended

Period: 2026-02-27

President, U.S. Group Health

Transactions

Award
Performance Stock Units
[F1][F2][F3][F4]
2026-02-27+15,596→ 15,596 total
→ Common Stock (15,596 underlying)
Exercise/Conversion
Performance Stock Units
[F5][F6][F4]
2026-02-27−5,198→ 10,398 total
→ Common Stock (5,198 underlying)

Footnotes (6)

[F1]Each performance stock unit represents a contingent right to receive one share of TDOC common stock.
[F2]Performance award amount determined based on metrics in respect of the issuer's 2025 financial results.
[F3]The performance stock units vest as to one-third on March 1, 2026, with the remainder vesting in eight substantially equal quarterly installments thereafter.
[F4]The Form 4 filed March 3, 2026, inadvertently included an incorrect amount for the number of performance stock units awarded. This amendment reports the correct amount.
[F5]Performance stock units convert to shares of TDOC common stock on a one-for-one basis.
[F6]On March 1, 2026, the reporting person earned 15,596 performance stock units, vesting one-third on March 1, 2026, with the remainder vesting in eight substantially equal quarterly installments thereafter.

Signature

/s/ Adam C. Vandervoort, Attorney-in-Fact|2026-03-12

1 file